Prognostic Significance of Endogenous‐Type Coronary Microvascular Dysfunction in the Left Anterior Descending Artery After Elective Percutaneous Coronary Intervention
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70182 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2025. Written by Takahiro Watanabe and 12 co-authors. Institution: Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan. Major MEDLINE topics: Percutaneous Coronary Intervention, Microcirculation, Coronary Circulation, Coronary Artery Disease. 23 references. Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background
Coronary microvascular dysfunction (CMD) can be phenotyped as endogenous or classical.
Aims
This study investigated the prognostic significance of these CMD endotypes in patients with chronic coronary syndrome after elective percutaneous coronary intervention (PCI).
Methods
This retrospective study included 205 patients who underwent elective PCI in the left anterior descending artery (LAD). Post‐PCI, coronary flow was assessed using stress transthoracic Doppler echocardiography to measure diastolic peak flow velocity (DPV) and calculate coronary flow velocity reserve (CFVR). CMD was defined as CFVR ≤ 2.0 and further classified as endogenous (resting DPV > 33 cm/s) or classical (resting DPV ≤ 33 cm/s). This cutoff was determined by the 34.6th percentile of sorted DPV values, corresponding to reduced CFVR distribution. The primary endpoint was major adverse cardiac events (MACE), a composite of cardiac death, myocardial infarction, heart failure hospitalization, and target vessel revascularization.
Results
Over a median follow‐up of 2.3 years, 30 patients (14.6%) experienced MACE. The cumulative incidence of MACE was significantly higher in patients with endogenous‐type CMD compared to those with classical‐type CMD or without CMD ( p < 0.001). In multivariate Cox proportional hazard analysis, endogenous‐type CMD remained an independent predictor of MACE (hazard ratio: 3.28; 95% confidence interval: 1.53–7.04; p = 0.002).
Conclusions
Endogenous‐type CMD in the LAD territory following elective PCI is an independent predictor of MACE. Noninvasive phenotyping of CMD post‐PCI using stress echocardiography may improve risk stratification and guide personalized management strategies for these high‐risk patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan.
- Department of Cardiovascular Medicine, Institute of Science Tokyo, Tokyo, Japan.
ORCID profiles: Takahiro Watanabe, Masahiro Hada, Hikaru Shimosato, Tsunekazu Kakuta
Funding
- The authors received no specific funding for this work.
Cite
APA
Watanabe, T., Kanaji, Y., Usui, E., Hada, M., Nagamine, T., Ueno, H., Setoguchi, M., Sayama, K., Shimosato, H., Mineo, T., Yonetsu, T., Sasano, T., & Kakuta, T. (2025). Prognostic Significance of Endogenous‐Type Coronary Microvascular Dysfunction in the Left Anterior Descending Artery After Elective Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70182
Vancouver
Watanabe T, Kanaji Y, Usui E, Hada M, Nagamine T, Ueno H, et al. Prognostic Significance of Endogenous‐Type Coronary Microvascular Dysfunction in the Left Anterior Descending Artery After Elective Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70182
BibTeX
@article{Watanabe2025,
author = {Watanabe, Takahiro and Kanaji, Yoshihisa and Usui, Eisuke and Hada, Masahiro and Nagamine, Tatsuhiro and Ueno, Hiroki and Setoguchi, Mirei and Sayama, Kodai and Shimosato, Hikaru and Mineo, Takashi and Yonetsu, Taishi and Sasano, Tetsuo and Kakuta, Tsunekazu},
title = {Prognostic Significance of Endogenous‐Type Coronary Microvascular Dysfunction in the Left Anterior Descending Artery After Elective Percutaneous Coronary Intervention},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70182}
}
EUVIMED